Exane Derivatives’s Paycom PAYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$84.9K Sell
303
-557
-65% -$164K 0.05% 278
2022
Q1
$298K Buy
860
+91
+12% +$30.5K 0.08% 248
2021
Q4
$319K Buy
769
+519
+208% +$246K 0.08% 256
2021
Q3
$124K Hold
250
0.03% 494
2021
Q2
$93K Buy
250
+100
+67% +$35.4K 0.02% 547
2021
Q1
$55.5K Hold
150
0.02% 505
2020
Q4
$67.8K Buy
+150
New +$59.8K 0.02% 434

Other funds holding PAYC

Exane Derivatives's PAYC Position: Q2 2022 in Review

Exane Derivatives reduced its Paycom (PAYC) stake by 65% in Q2 2022, selling an estimated $164K and leaving 303 shares worth $84.9K. The position accounts for 0.05% of the portfolio, ranked #278.

Exane Derivatives first reported a position in PAYC in Q4 2020 and has held it in 7 quarters since. The position peaked at $319K in Q4 2021. 648 funds tracked by Wall St. Rank hold PAYC as of Q2 2022.

  • Exane Derivatives held 303 shares of Paycom worth $84.9K as of Q2 2022.
  • Exane Derivatives sold 557 Paycom shares in Q2 2022, an estimated $164K.
  • Paycom made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #278 holding.
  • Exane Derivatives first reported a position in Paycom in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Paycom position peaked at $319K in Q4 2021.
  • 648 funds tracked by Wall St. Rank held Paycom as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.